Patents by Inventor Kwanghee Baek

Kwanghee Baek has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11155635
    Abstract: The present invention relates to an antibody specifically bound to a coagulation factor VIII or an antigen binding fragment thereof, and a use thereof. More specifically, the present invention relates to: an antibody which is specifically bound to a coagulation factor VIII including specific sequences of heavy chain CDR and light chain CDR, or an antigen binding fragment thereof; a column in which the antibody or the antigen binding fragment thereof is coupled to a column stationary phase as a ligand for isolating or purifying a recombinant coagulation factor VIII; and a method for purifying a recombinant coagulation factor VIII using the same.
    Type: Grant
    Filed: December 14, 2017
    Date of Patent: October 26, 2021
    Assignee: PANGEN BIOTECH INC.
    Inventors: Jaeseung Yoon, Kwanghee Baek, Taeho Byun, Jeong Soo Park, Ji Tai Kim, Hankyu Oh, Jongmin Lee
  • Publication number: 20200277401
    Abstract: The present invention relates to an antibody specifically bound to a coagulation factor VIII or an antigen binding fragment thereof, and a use thereof. More specifically, the present invention relates to: an antibody which is specifically bound to a coagulation factor VIII including specific sequences of heavy chain CDR and light chain CDR, or an antigen binding fragment thereof; a column in which the antibody or the antigen binding fragment thereof is coupled to a column stationary phase as a ligand for isolating or purifying a recombinant coagulation factor VIII; and a method for purifying a recombinant coagulation factor VIII using the same.
    Type: Application
    Filed: December 14, 2017
    Publication date: September 3, 2020
    Inventors: Jaeseung YOON, Kwanghee BAEK, Taeho BYUN, Jeong Soo PARK, Ji Tai KIM, Hankyu OH, Jongmin LEE
  • Patent number: 9062326
    Abstract: There is provided an expression vector for animal cell having an increased gene expression efficiency, and particularly, an expression vector for animal cells including a MAR element and a SAR element, which are gene expression increasing factors, at a 5? end of a promoter, a 3? end of a transcription termination site, or at both of the 5? end of the promoter and the 3? end of the transcription termination site. The expression vector for animal cells according to the present invention exhibits remarkably increased gene expression efficiency as compared to conventional expression vectors for animal cells, such that protein expression of foreign genes may be significantly increased using this expression vector for animal cells. Particularly, the expression vector for animal cells according to the present invention may be useful in that a high-expression cell line may be secured even without MTX amplification.
    Type: Grant
    Filed: March 30, 2012
    Date of Patent: June 23, 2015
    Assignee: PANGEN BIOTECH INC.
    Inventors: Jaeseung Yoon, Kwanghee Baek, Taeho Byun, JeongSoo Park
  • Publication number: 20140038233
    Abstract: There is provided an expression vector for animal cell having an increased gene expression efficiency, and particularly, an expression vector for animal cells including a MAR element and a SAR element, which are gene expression increasing factors, at a 5? end of a promoter, a 3? end of a transcription termination site, or at both of the 5? end of the promoter and the 3? end of the transcription termination site. The expression vector for animal cells according to the present invention exhibits remarkably increased gene expression efficiency as compared to conventional expression vectors for animal cells, such that protein expression of foreign genes may be significantly increased using this expression vector for animal cells. Particularly, the expression vector for animal cells according to the present invention may be useful in that a high-expression cell line may be secured even without MTX amplification.
    Type: Application
    Filed: March 30, 2012
    Publication date: February 6, 2014
    Applicant: PANGEN BIOTECH INC.
    Inventors: Jaeseung Yoon, Kwanghee Baek, Taeho Byun, JeongSoo Park
  • Patent number: 7259010
    Abstract: The present invention relates to mammalian expression vectors including nuclear matrix attachment region of human interferon ?, and more particularly to pPGM-1, pPGM-2 and pPGM-3 including nuclear matrix attachment region of interferon ? gene. Those expression vectors confer position independent expression of the introduced foreign gene, thus increasing the frequency of colonies which efficiently express the recombinant protein.
    Type: Grant
    Filed: December 14, 2001
    Date of Patent: August 21, 2007
    Assignee: Pangen Biotech Inc.
    Inventors: Jeong Do Kim, Hye-Yeon Hwang, Dong-jun Kim, Kwanghee Baek, Yeup Yoon, Jaeseung Yoon, Alex Inkeun Leesong
  • Publication number: 20040072352
    Abstract: The present invention relates to mammalian expression vectors including nuclear matrix attachment region of human interferon &bgr;, and more particularly to pPGM-1, pPGM-2 and pPGM-3 including nuclear matrix attachment region of interferon &bgr; gene. Those expression vectors confer position independent expression of the introduced foreign gene, thus increasing the frequency of colonies which efficiently express the recombinant protein.
    Type: Application
    Filed: November 10, 2003
    Publication date: April 15, 2004
    Inventors: Jeong Do Kim, Hye-Yeon Hwang, Dong-Jun Kim, Kwanghee Baek, Yeup Yoon, Jaesung Yoon, Alex Inkeun Leesong